Nucala vs Advair Diskus
A side-by-side look at two respiratory medications advertised on TV. Informational only — not medical advice.
| US Nucala | US Advair Diskus | |
|---|---|---|
| Generic name | mepolizumab | fluticasone/salmeterol |
| Drug class | IL-5 Antagonist (Biologic) | Inhaled Corticosteroid / LABA Combination |
| Treats | Severe eosinophilic asthma, COPD, nasal polyps | Asthma and COPD |
| Category | Respiratory | Respiratory |
| Manufacturer | GSK | GSK |
| Year approved | 2015 | 2000 |
| FDA warning | No boxed warning | Moderate warnings |
| Est. TV ad spend | $75M | — |
| Common side effects | Headache, Injection site reactions, Back pain, Fatigue | Thrush (mouth infection), Hoarse voice, Headache, Throat irritation |
Advair Diskus
Frequently asked questions
Is Nucala or Advair Diskus better?
Neither is universally "better." Nucala (mepolizumab) and Advair Diskus (fluticasone/salmeterol) are both used for respiratory, but the right choice depends on your medical history, insurance and your doctor's guidance. This comparison is informational only.
What's the difference between Nucala and Advair Diskus?
Nucala is a IL-5 Antagonist (Biologic) made by GSK, while Advair Diskus is a Inhaled Corticosteroid / LABA Combination made by GSK. See the table above for a side-by-side breakdown.
Which one spends more on TV ads?
Nucala has the larger estimated TV advertising budget of the two.